EU proposes alternative to IP waiver to expand global vaccine access
The EU on Friday (4 June) set out its plan to boost deliveries of COVID-19 vaccines to developing countries, which banks on open supply chains, encouraging production and compulsory licences rather than waiving intellectual property rights.
